Your search returned 2 results.

Results
	1.	A Phase I study of the angiogenesis inhibitor SU5416 (semaxanib) in solid tumours, incorporating dynamic contrast MR pharmacodynamic end points. [electronic resource] by O'Donnell, A Padhani, A Hayes, C Kakkar, A J Leach, M Trigo, J M Scurr, M Raynaud, F Phillips, S Aherne, W Hardcastle, A Workman, P Hannah, A Judson, I Producer: 20051121 In: British journal of cancer vol. 93 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Combination antiangiogenesis therapy with marimastat, captopril and fragmin in patients with advanced cancer. [electronic resource] by Jones, P H Christodoulos, K Dobbs, N Thavasu, P Balkwill, F Blann, A D Caine, G J Kumar, S Kakkar, A J Gompertz, N Talbot, D C Ganesan, T S Harris, A L Producer: 20040806 In: British journal of cancer vol. 91 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search